Welcome back to Higher Law, our weekly briefing on all things cannabis. I’m Cheryl Miller, reporting for Law.com from Sacramento, where we’re holding paint swatch strips to the sky to see what shade of sepia adequately describes the smoky muck above us today.
This week we’re looking at: Crystal-balling the FDA and CBD • Tracking state laws on moving consumables • A lawsuit targeting CannaRegs • The political pros and cons of pursuing marijuana decriminalization
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]